Patent Yard Sign in
Canadian application, no grantCanada

Methods for treating neurological injuries and disorders

CA 2336718 A1 · Owner: Marchionni, Mark · Inventors: Ebendal, Ted; Marchionni, Mark; Jarpe, Michael

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

The present invention relates to methods for treatment of nerve cell death (degeneration) and neurodegenerative diseases. Methods of the invention include administering an effective amount of GDF-1 alone or in combination with neurotrophin-3, to a patient in need of such treatment such as a person suffering from stroke or traumatic brain injury or a neurodegenerative disease.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed July 2, 1999. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended July 2, 2019.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by July 2, 2021.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledJuly 2, 1999
GrantedNo grant recorded
Term endedJuly 2, 2019
Patent numberCA 2336718 A1
Classification (IPC)A61K31/71 +2 more

Timeline

Timeline From CIPO dates

2000200220042006200820102012201420162018Application filedJuly 2, 1999Term endedJuly 2, 2019

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.